The oncology biosimilars market stood at US$ 1,651.5 Mn in 2017 and projected to exhibit a double-digit compound annual growth rate (CAGR) of 28.3% during the forecast period from 2018 to 2026. According to U.S. Food and Drug Administration, biosimilars are biological medicines that contain a highly similar version of the active substance of an already approved biologic, commonly referred to as the reference product.

The human microbiome market is set to reach US$ 1,990.5 Mn by 2026 from US$ 840.1 Mn in 2017 at a compound annual growth rate (CAGR) of 10.1% during the forecast period from 2018 to 2026. According to the research findings of World Health Organization (WHO), the burden associated with non-communicable diseases is set increase to 57% by 2020.

Plant-based meat protein is treated as an animal meat protein substitute which is mainly made of soy or gluten. It does not involve any animal product like meat or dairy. There are two methods by which plant-based meat products are processed: thermoplastic extrusion and fiber spinning.

The global genomics market held US$ 13,122.9 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 10.4% during the forecast period from 2018 to 2026. The exploration of genomics has surpassed in the last three decades to massive advancements in the technology that allowed the researchers to sequence larger pieces of genome.

Cell proliferation kits are assay based test solutions that aid in the quantification of cell proliferation and viability. Proliferation tests are based on the division of tetrazolium salt WST-1 to formazan by the activity of cellular mitochondrial dehydrogenases.

Global biologics market accounted for market value of US$ 254.9 Bn in 2017 and expected to attain US$ 580.5 Bn by 2026. Recombinant therapeutic proteins contributed largest market share in 2017 while cellular and gene therapies exhibited fastest annual growth during the forecast period from 2018 to 2026.

Microscopy plays a central role in the field of life science in order to observe biological structure. It successfully allows to expand its usage in various domain of life science to get a magnified version of objects. The wide range of microscopy device varies in terms of degree of magnification, image resolution and the technology involved. The necessity of microscope is to gain a clear picture of biological structure in terms of diagnosis and treatment of any medical condition. Microscopy devices contributes significantly in the recent developments of drug discovery to cure diseases and to enhance quality of life.

The most common application of immunohistochemistry is to study and identify the site of origin of metastatic tumor when the primary site has already been identified. Technological advancement in the panel of immunostains can be helpful in resolving all diagnostic problems. Recent antibodies such as cadherin-17, SATB2, CDX-2 and villin have found application in the differential diagnosis of suspected metastatic adenocarcinoma.

Industrial microbiology refers to screening of microorganisms for production of pharmaceuticals, food and beverage, personal care products and other applications. The industrial microbiology market is significantly large and is perpetually growing. Industries worldwide perform billions of tests every year thus representing substantial market potential.

The global bacteriophage market held US$ 567.9 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 3.9% during the forecast period from 2018 to 2026. Bacteriophages are estimated as the most widely distributed and varied entities in the biosphere. From the initial research that defined the nature of viruses, bacteriophages have become model organisms for understanding the biochemistry.

The life science instrumentation market is set to reach US$ 100,792.7 Mn by 2027 from US$ 57,185.5 Mn in 2018 showcasing moderate growth at a compounded annual growth rate (CAGR) of 6.5% during the forecast period from 2019 to 2027. Technological advancement in the life science instruments and stringent healthcare norms pertaining to food and drug manufacturing process drive the market growth for life science instrumentation techniques. Rising public health awareness and proactive government policies to curb the mortality associated with chronic diseases further propel the demand for life science instrumentation technology in the pharmaceutical and biotechnology companies.

The cell expansion market is set to reach from US$ 9,743.7 Mn in 2018 to US$ 33,443.2 Mn by 2027 at a compound annual growth rate (CAGR) of 15.0% during the forecast period from 2019 to 2027. Lack of effective treatment regime for the chronic disease has resulted in significant rise in novel drug discovery and development research studies throughout the globe. Increasing demand for regenerative medicine and stem cell therapy further consolidates the cell expansion market growth.

Immune Repertoire Sequencing refers to novel approach to next generation sequencing that helps to understand and examine immune mediated diseases. The Global market for Immune Repertoire Sequencing is expected to witness a substantial growth, growing at a CAGR of approximately 8% over the forecast period of 2019-2026. Immune repertoire sequencing is among the most accurate and sensitive platform for the profiling of antigen specific information within lymphocytes. The main advantage with this technique is that it is minimally invasive in nature and requires low amount of sample. The market for Immune repertoire sequencing is primarily driven by growing prevalence of cancer, growing research in the field of immunotherapy along with growing pharmaceutical R&D expenditure.

The purpose of this research study titled ‘Rat Model Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025’ is to provide investors, developers, company executives and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global rat model market. This report presents and analyzes the major trends prevalent in the global rat model market and the market size and forecast.

The global polymeric nanoparticles market is estimated to grow at an impressive rate during the forecast period of 2016-2022. Polymer nanoparticles have attracted mostly the research groups and are being used in a rising number of areas during the last years. Naturally, two prime strategies are applied for their preparation: the polymerization of monomers and the dispersion of preformed polymers.

The regenerative medicine market is expected to grow with a robust CAGR of 14% in the forecast period of 2016 to 2022. In 2015, the market has generated the revenue of $ 3.85 billion and is expected to reach up to $9.64 billion by 2022. The fast growing advancements in stem cell technology; thepotentialsof nanotechnology; and,rising cases of chronic diseases and trauma injuriesare the major drivers for the regenerative medicine,globally.The increasing demand and awareness of steam cells also helps to increase themarket forregenerative medicine.

According to the FDA,”the companion diagnostic device is a medical device, often an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product. The test helps a health care professional determine whether a particular therapeutic product’s benefits to patients will outweigh any potential serious side effects or risks”.

Conventionally, 2D cell culture have being used regularly in laboratories across the world. However, 2D cell culture has become primitive and are not able to replicate the exact in vivo environment. With advent of technology 3D cell culture model is able to exhibit similar environment close to the complex in vivo conditions. 3D cell culture is the assembly of living cell in three dimensional structure resembling particular tissue and organ microarchitecture. 3D cell culture can be made using scaffold or scaffold-free methods. 3D Cell culture model have wide range of applications ranging from tissue engineering to drug development, discovery and screening.

Next generation sequencing is a high-throughput sequencing that enables sequencing and assembling of number of short DNA reads at a small period of time and with a better accuracy. Next-generation sequencing (NGS) technologies have progressive advantages in terms of cost-effectiveness, unprecedented sequencing speed, high resolution and accuracy in genomic analyses. 

The global microbial product technology market is expected to grow with a CAGR of 15.1% during the forecasted period 2015-2022. The major factors contributing towards the growth in market isescalating incidences of infectious diseases in the global market. The demand for microbial product is mainly attributed from agriculture industry, as the agriculture industry has been estimated to grow with an eye popping CAGR in the forecasted period.The growth in agriculture industry is mainly driven by the increasing demand for organic products in the global market.